• Funding renewal supports advanced therapies sector
    Matthew Durdy

Company News

Funding renewal supports advanced therapies sector

Feb 02 2024

An £80 million award granted under Innovate UK’s £1.6bn Catapult programme, will help to drive the Cell and Gene Therapy Catapult’s (CGT Catapult) activities in continuing to build the UK’s thriving advanced therapies industry until March 2028. The figure represents a 35% increase compared to the previous five years and will enable the Catapults to generate more impact, fostering enhanced strategic coherence and ensuring optimal value for the taxpayer.

Operating in four locations across the UK, CGT Catapult works with industry, academia and the healthcare system, helping researchers to commercialise their discoveries, industry to develop efficiency in manufacture of advanced therapies and the NHS to effectively deliver these new modalities. Along with provision of upskilling and training for the existing and future workforce, the work of the CGT Catapult has impacted all stages of the advanced therapies lifecycle.

Matthew Durdy, Chief Executive of the CGT Catapult, said: “We would like to thank our colleagues at Innovate UK for their support and the people of the CGT Catapult for their relentless commitment, as well as all of our collaborators who make our projects and delivery possible. This funding will enable us to continue our work with the advanced therapies sector, helping the industry grow, creating high productivity employment and ultimately helping more patients receive the life-changing cell and gene therapies they need.”

More information online


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Water Expo Nigeria 2024

May 21 2024 Lagos, Nigeria

Discovery Europe 2024

May 22 2024 Basel, Switzerland

NGVS 2024

May 23 2024 Beijing, China

Analiza

May 28 2024 Tel Aviv, Israel

View all events